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A B S T R A C T
Protein misfolding and aggregation have been associated with the onset of neurodegenerative disorders. Recent
studies demonstrate that the aggregation process can result in a high diversity of protein conformational states,
however the identity of the speciﬁc species responsible for the cellular damage is still unclear. Here, we use yeast
as a model to systematically analyse the intracellular eﬀect of expressing 21 variants of the amyloid-ß-peptide,
engineered to cover a continuous range of intrinsic aggregation propensities. We demonstrate the existence of a
striking negative correlation between the aggregation propensity of a given variant and the oxidative stress it
elicits. Interestingly, each variant generates a speciﬁc distribution of protein assemblies in the cell. This allowed
us to identify the aggregated species that remain diﬀusely distributed in the cytosol and are unable to coalesce
into large protein inclusions as those causing the highest levels of oxidative damage. Overall, our results indicate
that the formation of large insoluble aggregates may act as a protective mechanism to avoid cellular oxidative
stress.
1. Introduction
Protein aggregation and the long term accumulation of amyloid
protein inclusions (PI) in the central nervous system are pathognomonic
signs of devastating neurodegenerative disorders like Alzheimer's (AD),
Parkinson's (PD) and Huntington's (HD) diseases [1–5]. In spite of this,
it is becoming evident that the coalescence of proteins and other
molecules into dynamic liquid-like assemblies is essential for an
increasing number of cellular processes [6–8]. In contrast, the bene-
ﬁcial or detrimental eﬀects associated with the formation of insoluble
protein aggregates are still under debate.
Cells have evolved two main mechanisms against protein aggrega-
tion: (i) refolding of misfolded conformers by chaperones and (ii)
targeted destruction of damaged proteins by the ubiquitin-proteasome
and/or autophagy systems [9–14]. The presence of PI in neurodegen-
erative diseases has been traditionally assumed to reﬂect the insuﬃ-
ciency of this ﬁrst line of defence [15]. However, it was proposed later
that the formation of PI can instead act as a protective strategy [16,17],
triggering an intense dispute on the speciﬁc protein species responsible
for the cellular damage [18,19]. It has been suggested that earlier
aggregation intermediates, such as oligomeric and/or protoﬁbrillar
assemblies, would disrupt the cellular homeostasis by promoting
aberrant interactions with diﬀerent cellular components [20], including
the protein quality surveillance machinery, whereas the formation of
inclusions at speciﬁc cellular sites might be indeed a detoxifying
mechanism against the presence of these promiscuous species
[17,21]. In agreement, studies in AD, PD and HD models report that
the presence of PI might represent a marker, rather than a cause of the
disease and that the continuous presence of aggregative species
constitutes the main toxic insult for the cell [17,22].
Oxidative stress plays a central role in the pathophysiology of the
diﬀerent neurodegenerative diseases linked to protein aggregation
[23]. Cumulative oxidative stress induces membrane damage, impair-
ment of the DNA repair system and mitochondrial dysfunction, which
ultimately can lead to cell death [24,25]. Accordingly, there is clear
evidence of oxidative damage in postmortem AD, PD and HD brains
[26–28]. The mechanism by which aggregating proteins may induce
oxidative stress in the brain is not completely understood, but the
interaction between these two phenomena is bidirectional, in such a
way that aggregation-prone conformers increase the production of
reactive oxygen species (ROS), while at the same time oxidative stress
exacerbates protein aggregation [28]. Again, there is discrepancy on
the nature of the aggregating species causing the oxidative damage,
some reports attributing this property to early oligomers [20] and
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others indicating that PI constitute centres of oxidative events, ques-
tioning their cytoprotective role [29].
The use of simple cellular models has led to great advances in the
study of neurodegenerative disorders. The budding yeast Saccharomyces
cerevisiae shares with higher eukaryotes numerous fundamental cellular
pathways involved in neurodegeneration, such as protein quality
control, autophagy or the regulation of the cellular redox state
regulation [30,31]. Thanks to this, humanized yeast models for AD,
PD and HD have been successfully developed, recapitulating some of
the pathological features associated with these disorders, including
oxidative stress [32–38]. We have previously exploited yeast to dissect
the relationship between proteins aggregation in vivo and their physi-
cochemical properties. For this purpose, we designed and expressed
intracellularly 20 diﬀerent variants of the amyloid-β-peptide (Aβ42)
fused to GFP [39]. Later, we investigated the proteomic response
caused by the expression of two individual proteins from this collection
displaying diﬀerent in vivo aggregation properties, one of them
remaining diﬀusely distributed in the cytosol and the other one forming
large PI in yeast cells. The main diﬀerences between the proteomic
response elicited by these two Aβ42 variants were related to redox
homeostasis [40]. This anticipated that the complete Aβ42-GFP set
might be employed as a tool to dissect quantitatively the contribution of
diﬀerent aggregating species to oxidative damage. To this aim, in the
present study we performed a systematic investigation of the relation-
ship between the intrinsic aggregation propensities of 21 Aβ42-GFP
variants, their ability to be recruited into PI and the induced intracel-
lular oxidative stress. With these analyses, we demonstrate the ex-
istence of a conspicuous inverse relationship between Aβ42 peptides
aggregation propensities and oxidative stress levels, distinguishing
peptide variants unable to be recruited into inclusions as those causing
the highest levels of oxidative damage. In this way, we identiﬁed as the
elicitors of the oxidative insult those species that despite being in an
aggregated state remain diﬀusely distributed in the cytosol, available
for establishing disrupting non-functional interactions. Overall, our
data provide strong support for the detoxifying role against oxidative
stress played by PI.
2. Material and methods
2.1. Protein expression in Saccharomyces cerevisiae
Yeast cells BY4741 (MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)
transformed as previously described [39,41] with pESC(-Ura) plasmid
(Addgene) encoding for the Aβ42-GFP protein and 19 variants diﬀering
only in the residue in position 19th of the peptide, together with the
variant F19D/L34P were grown overnight in glucose SC-URA medium
at 30 °C, and 100 µL was used to inoculate 5 mL of fresh medium. At an
OD590 of 0.5, cells were changed to a fresh raﬃnose SC-URA medium.
After 30 min of incubation, cells were changed again to a fresh SC-URA
medium containing 2% of galactose, as a carbon source, to induce the
recombinant protein expression during 8 h, 16 h and 48 h. Cells were
harvested and pellets were stored at −80 °C.
2.2. Prediction of aggregation propensities
The aggregation propensity of the generated variants was analysed
using three diﬀerent algorithms: (i) AGGRESCAN (http://bioinf.uab.es/
aggrescan/) [42], (ii) TANGO (http://tango.crg.es/) [43] and (iii)
FoldAmyloid (http://bioinfo.protres.ru/fold-amyloid/) [44]. Aggrega-
tion propensities were calculated using the default settings.
2.3. Fluorescence and confocal microscopy
Cells expressing selected Aβ42-GFP variants for 8 h, 16 h and 48 h
were washed with PBS and visualised by ﬂuorescence microscopy
(Nikon Eclipse TE200E). Cells were washed with PBS before image
acquisition at 100-fold magniﬁcation. GFP ﬂuorescence was acquired
with a 482/35 nm laser and emission was collected at 536/40 nm. The
cultures expressing Gln and Ile variants of Aβ42-GFP during 16 h, were
added 10 µM dihydroethidium (Life Technologies) and incubated for
10 min in dark at 30 °C. Cells were washed in PBS, and deposited on top
of glass slides. Images were obtained under UV light using a ﬁlter for
GFP excitation (450–500 nm) and collecting with an emission range
(515–560 nm) in a Leica ﬂuorescence microscope (Leica Microsystems,
Germany), while the ﬂuorescence of dihydroethidium was excited using
a 521–565 nm ﬁlter and the emission was collected at 553–633 nm.
Image acquisition and data analysis were performed using NIS elements
imaging software.
2.4. Flow cytometry analysis
Yeast cells after 8 h, 16 h and 48 h of expression were washed and
resuspended in sterile PBS to an OD590 of 0.1. Flow cytometry
measurements were performed using a BD FACSCanto ﬂow cytometer
(BD Biosciences) equipped with a 488 nm blue laser (for GFP) and
635 nm red laser (for CellROX and propidium iodide). Gated cells (by
means of FSC and SSC parameters) were analysed for green emission
measured on 530/30 nm BP ﬁlter and for deep red emission on 660/20
BP ﬁlter. Obtained data from 10,000 events were analysed using BD
FACSDiva software (BD Biosciences) and the median ﬂuorescence
intensities at the emission maximum were obtained.
2.5. Oxidative stress detection
5 μM CellROX Deep Red Reagent (Life Technologies) was added and
cells were incubated at 30 °C, for 30 min in the dark. After incubation,
cells were washed 3 times and resuspended in the same volume of PBS
before their analysis with ﬂow cytometry.
2.6. Propidium iodide staining
Cell pellets were resuspended in PBS to an OD590 of 0.1. and
incubated for 20 min with 2 μg/mL propidium iodide (here abbreviated
IP to avoid confusion with protein inclusions (PI)). After incubation,
cells were washed 3 times and resuspended in the same volume of PBS
before their analysis with ﬂow cytometry.
2.7. ROS assay
Hydrogen peroxide levels were determined using Red Hydrogen
Peroxide Assay Kit (Enzo Life Sciences) according to manufacturer's
protocol. 10 mL of cells induced for 16 h were harvested and resus-
pended in lysis buﬀer (20 mM phosphate buﬀer, 5 mM EDTA, 0.2 mM
PMSF, pH 7.2). Cells were broken using glass beads (0.5 mm diameter)
by vortexing eight times for 1 min with intervals of 1 min on ice.
Supernatant was removed to new tubes and the concentration of total
protein was determined by Bradford method. The conversion of red
peroxidase substrate was determined by monitoring the ﬂuorescence
increase with an excitation at 531 and an emission ﬁlter at 595 nm in a
Victor 3 Plate Reader (Perkin-Elmer).
2.8. Antioxidant enzyme activity determination
The catalase (CAT) activity was determined using Catalase Assay Kit
(Sigma-Aldrich) according to manufacturer's protocol. 10 mL of cells
expressing for 16 h were harvested, resuspended in lysis buﬀer (10 mM
HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF, pH
7.9) and broken as described above. The amount of remaining H2O2
after the action of catalase was determined by measuring the absor-
bance of red quinoneimine dye at 550 nm in a Victor 3 Plate Reader
(Perkin-Elmer).
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2.9. Protein carbonylation determination
Yeast cells after 16 h of expression were broken by repeated
vortexing in cold conditions using glass beads (0.6 mm diameter).
Total protein extracts were centrifuged at 10,000 rpm for 10 min in
order to obtain soluble fractions and at 13,000 rpm for 30 min in order
to obtain insoluble fractions. Obtained fractions were boiled in 6% SDS
at 90 °C for 3 min and stored at −20 °C for further analysis. Before
adding SDS the concentration of the fractions was determined by
Bradford method. The analysis of protein oxidation for soluble and
insoluble fractions were performed by derivatization of carbonyl groups
with dinitrophenylhydrazine (DNPH), followed by SDS–PAGE, transfer
to PVDF membranes and western blotting, as described [45]. The
antibodies employed were: anti-DNP antibody (Dako) and goat anti-
rabbit IgG-HRP conjugate (Pierce). Bands were quantiﬁed by densito-
metry analysis using ImageLab (Bio-Rad). The level of carbonylation
detected for each individual Aβ42-GFP mutant was normalised relative
to the one exhibited by control cells expressing GFP alone.
2.10. Immunoblotting analysis
Collected cells were resuspended in PBS. 200 µL of each mutant was
prepared to an OD590 of 20. For soluble/insoluble fraction analysis,
100 µL of each mutant was harvested by centrifugation and resus-
pended in the same volume of Y-PER protein extraction reagent
(Thermo Scientiﬁc), supplemented with 1 mM PMSF, and incubated
for 20 min at room temperature under mild agitation. Then the protein
extract concentration was determined by Bradford method. Samples
were centrifuged at maximum speed for 15 min. Soluble fractions were
removed to new tubes and insoluble fractions were resuspended in
100 µL of PBS containing PMSF. 5 µL of soluble and insoluble fractions
of each sample were loaded on a 15% SDS-PAGE and blotted onto a
PVDF membrane. The antibodies employed were: β-amyloid antibody
6E10 (BioLegend) and goat anti-mouse IgG-HRP conjugate (Bio-Rad).
Membranes were developed with Luminata (Milipore) and bands were
quantiﬁed by densitometry analysis using Quantity One software (Bio-
Rad).
2.11. Proteinase K resistance assay
Insoluble fractions, obtained as described above, were incubated
with 10 μg/mL proteinase K (PK) (Sigma-Aldrich) in PBS at 37 °C.
Aliquots digested with PK were taken at 5 and 10 min and the reaction
quenched by the addition of the same amount of 4 times concentrated
denaturing sample buﬀer. Samples were heated at 99 °C for 10 min and
5 µL of each sample was loaded on SDS-PAGE. After blotting onto a
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Fig. 1. GFP ﬂuorescence determined in S. cerevisiae cultures expressing Aβ42-GFP mutants for 16 h. (A) Representative ﬂuorescence microscopy images of yeast cells expressing selected
Aβ42-GFP variants (Asp, Gln, Thr, Phe and Ile). Scale bar represents 10 µm. (B) 3D bar graph representing the relative aggregation propensities of 20 natural amino acids, derived from
the analysis of mutants in central position of the central hydrophobic cluster in amyloid-β-protein previously described by de Groot et al. [49], represented on the primary y-axis, together
with the percentage of cells containing intracellular visible ﬂuorescent protein inclusions (PI) for Aβ42-GFP variants represented on the secondary y-axis. The dashed black line represents
deﬁned threshold of PI formation. Values were obtained by determining the number of cells with PI among the ~ 500 cells from two diﬀerent cultures for each variant. (C) Correlation
between the percentage of cells containing visible intracellular PI and the intrinsic aggregation propensity predicted by AGGRESCAN (r =0.90, p≤0.0001).
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Fig. 2. Analysis of S. cerevisiae cultures expressing Gln, Thr and Ile mutants for 16 h. (A) Median ﬂuorescence values of expressed GFP from 10,000 cells determined by FC analysis (FITC-
A) for selected Aβ42-GFP variants. (B) CellROX median ﬂuorescence intensity (APC-A) (as indicator of oxidative stress levels) determined by FC for selected Aβ42-GFP variants. Error bars
represent CV of the FC gated cells (P3 population). (C) H2O2 levels determined by monitoring the ﬂuorescence at 595 nm for selected Aβ42-GFP variants. Error bars represent± SE
(n=3). (D) Catalase activity determined by absorbance measures at 550 nm for selected Aβ42-GFP variants. Error bars represent± SE (n=3). (E) Immunodetection of protein
carbonylation levels of insoluble cell fractions for selected Aβ42-GFP variants. All samples were run in the same gel. The places where the membrane was trimmed are indicated by a thin
line. The normalised densities of the bands are: 135, 124, 88 and 100 a.u. for variants ordered from left to right, respectively. (F) The percentage of IP positive cells (as indicator of cell
mortality) was obtained by FC analysis (PerCP-Cy5-A) for selected variants. Error bars represent± SE (n=3). Cells expressing GFP alone were used as control.
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PVDF membrane, the digested fractions were detected by western
blotting as previously described.
2.12. Statistical analysis
Statistical signiﬁcance was determined using the two-tail t-Test. P
values< 0.05 were considered statistically signiﬁcant.
3. Results
3.1. The Aβ42-GFP protein collection
In the present study we used a set of 20 Aβ42-GFP variants that
correspond to all possible mutations for residue 19 in the Aβ42 peptide
[32]. This residue is located in the central hydrophobic cluster (CHC) of
the peptide and has an important inﬂuence in the peptide’s folding, self-
assembly and structure in the ﬁbrillar state [46,47]. Predictions of the
aggregation propensities of the resulting sequences using the AG-
GRESCAN algorithm [48] anticipated that this protein dataset would
display a continuum of aggregation propensities (Fig. S1). Analysis with
predictors based on diﬀerent physicochemical and structural protein
properties such as TANGO [43] and Foldamyloid [44] rendered very
similar aggregation gradation, ascribing in all cases the highest
aggregation propensities to the natural Aβ42 sequence (Phe19) and
those variants in which this residue is substituted by other aromatic or
aliphatic residues (Fig. S1).
3.2. PI formation propensity of Aβ42-GFP variants
The 20 Aβ–GFP proteins were expressed individually in yeast under
the control of the galactose-inducible GAL1 promoter to allow a rapid,
strong and synchronous induction of protein expression. All yeast cells
exhibited ﬂuorescence 16 h after induction of protein expression.
However, the formation of PI was observed only for 10 out of the 20
assayed variants. Representative images of selected PI-forming and
PI–non-forming variants are shown in Fig. 1A. The 10 PI-forming
variants correspond precisely with those proteins displaying the highest
aggregation propensity in the AGGRESCAN scale (Fig. 1B). This points
to a deﬁned protein aggregation propensity threshold governing the PI
formation in S. cerevisiae. In the conditions of our assay, this limit
corresponds to ∼ 45% of the aggregation potential of wild type Aβ.
Below this threshold, and independently of the considered mutant,
none of the cells in the population forms PI, whereas above this value
the proportion of cells displaying PI sharply depends on the identity of
the mutant, varying from 10% for Thr to> 60% for the wild type or the
Ile mutant. Then by focussing on the set of PI forming mutants, we
observed that the fraction of cells containing PI and the predicted
aggregation propensities according to AGGRESCAN signiﬁcantly corre-
late (r =0.90, p≤0.0001) (Fig. 1C). The slope of the regression line
(0.85) indicates that, above the aggregation threshold, a 10% increase
of protein aggregation propensity of the peptide results in an 8.5%
increase of the proportion of cells displaying protein inclusions.
3.3. The oxidative stress induced by Aβ42-GFP variants has a negative
correlation with their aggregation propensity
In order to decipher whether the formation of intracellular PI causes
or protects from oxidative stress, we selected three diﬀerent Aβ–GFP
variants for further study: i) Ile as a representative of high PI formation,
ii) Thr as a representative of low PI formation and iii) Gln as a variant
that does not generate PI.
In Aβ–GFP fusions, the GFP ﬂuorescence acts as a reporter of the
aggregation propensity, in such a way that more ﬂuorescence indicates
less aggregation and vice versa [49]. In agreement with the proportion
of PI forming cells, the median of the population ﬂuorescence measured
by ﬂow cytometry (FC) indicates that Gln is the most ﬂuorescent
variant, Ile is the less ﬂuorescent and Thr has a ﬂuorescence intensity in
between the other two (Fig. 2A).
Then we monitored the oxidative stress caused by the expression of
these variants by measuring four diﬀerent parameters: ROS production,
H2O2 levels, catalase activity and protein carbonylation. To monitor the
ROS production we analysed the cells expressing the three Aβ–GFP
variants with CellROX ﬂuorogenic probe and FC (Table S1). The Gln
variant exhibited the highest levels of ROS, followed by Thr and Ile
(Fig. 2B). Therefore, the more soluble variant (Gln) caused the highest
level of oxidative stress and the most aggregation-prone mutant (Ile)
turned out to be the most innocuous. These results were conﬁrmed by
the levels of H2O2 (Fig. 2C), again Gln exhibited the highest levels of
oxidative stress and Ile the lowest, with Thr displaying intermediate
H2O2 levels. In agreement, the enzyme catalase, which protects against
ROS, showed higher activity in yeast strains expressing the Gln variant
than in those expressing the Ile one (Fig. 2D). Protein carbonyl
formation is a marker for protein oxidation and can be detected by
DNPH derivatization followed by western blot with anti-DNP antibodies
[50]. We fractioned yeast cells and analysed the level of carbonylation
in both the soluble and insoluble protein fractions by western blot.
Whereas we did not observe any signiﬁcant diﬀerences between soluble
fractions, the level of protein oxidation was clearly higher in the
insoluble fraction of cells expressing the Gln variant than in those
expressing the Ile one (Fig. 2E).
In order to assess whether the recorded levels of oxidative stress
may impact cell ﬁtness, we analysed the viability of cells expressing the
diﬀerent variants by FC using propidium iodide (IP) staining. IP is a
DNA-binding dye that is excluded by live cells, but enters dead cells
with damaged membranes. In good agreement with their relative ROS
levels, the viability of the cell population was more compromised for
the Gln variant than for Ile (Fig. 2F).
The above described results suggest that PI formation is not the
main elicitor of cellular oxidative stress. To conﬁrm this, we used
confocal ﬂuorescence microscopy and dihydroethidium ﬂuorescence, a
marker of intracellular oxidative stress, to detect whether the cellular
distribution of Gln and Ile protein variants correspond with sites of ROS
production. In good agreement with the above described data, the
levels of ROS are higher in the more soluble Gln variant (Fig. 3). In both
cases, the oxidative stress is distributed in the cytosol and does not co-
localise with IP, suggesting that they are not centres of oxidative events
as proposed by other studies [21].
To address the relationship between protein aggregation properties
and oxidative stress in a more quantitative manner, we monitored the
levels of ROS for the rest of mutants belonging to the Aβ–GFP collection
using CellROX and FC (Table S1). Then, we compared the levels of ROS
with the aggregation propensity predicted by three diﬀerent algorithms
(Fig. 4A, Fig. S3A and S3B) and with all of them we obtained a
signiﬁcant negative correlation (AGGRESCAN: r =0.91, p≤0.0001;
TANGO: r =0.82, FoldAmyloid: p≤0.0001; r =0.84, p≤0.0001).
The aggregation propensity of a polypeptide sequence in a deﬁned
environment depends on its physicochemical properties [51]. In this
context, it has been found that β-sheet propensity and hydrophobicity
favour the self-assembly of proteins into aggregates. Consistently, our
results show that these two protein properties correlate negatively with
oxidative stress levels (β-sheet propensity: r =0.72, p≤0.0001, Fig. 4B;
hydrophobicity: r =0.78, p≤0.0001, Fig. 4C).
3.4. Both PI formation and aggregation-prone protein clearance prevent
oxidative stress
The comparison between GFP ﬂuorescence, an indication of aggre-
gation, and the oxidative stress shows a signiﬁcant positive relationship
(r =0.68, p≤0.0001) though the correlation coeﬃcient is lower than
the one observed for predicted aggregation propensities (Fig. 5A). In
this distribution, Trp and Phe are clear outliers, essentially because they
display lower ﬂuorescence than expected. This matches with the
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Fig. 3. Characterisation of GFP ﬂuorescence and oxidative stress levels for Gln and Ile variant. Representative confocal microscopy images of yeast cells expressing Gln and Ile variants
showing the levels of GFP ﬂuorescence (left), cellular oxidative stress (middle) and overlay image (right). Induced cultures were incubated with 10 µM dihydroethidium prior to image
acquisition. Scale bar represents 5 µm.
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Correlation between CellROX intrinsic ﬂuorescence and: (A) intrinsic aggregation propensity predicted by AGGRESCAN (r =0.91, p≤0.0001); (B) β-sheet propensity from Chou and
Fasman scale (r =0.72, p≤0.0001) and (C) hydrophobicity derived from the interface scale (r =0.78, p≤0.0001).
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smaller and less ﬂuorescent PI they exhibit, in comparison with the
other aggregation-prone mutants (Fig. S4). In addition, we have
previously shown that these observations are linked to the fact that
Trp and Phe mutants are recognised by the protein quality machinery
and degraded through autophagy [39], resulting in very low protein
levels (Fig. 6A). All these observations suggest that the degradation of
an aggregation-prone variant or sequestering it in PI may result in a
similar prevention of oxidative stress.
However, Trp and Phe are not the only responsible for the observed
lower correlation, since removing them from the dataset only increases
the correlation coeﬃcient to r=0.72 (p≤0.0001). We must consider
the observation that PI contribute much more to GFP ﬂuorescence than
they do to oxidative stress levels (Fig. 3). Thus, taking only into
consideration the ﬂuorescence of non-PI forming cells, the correlation
coeﬃcient raises to r=0.87 (p≤0.0001; Fig. 5B), supporting that PI
have a low impact on the generated oxidative stress levels.
3.5. Aggregated but diﬀusely distributed protein species are the elicitors of
oxidative damage
To further study the link between cellular oxidative stress and the
soluble/aggregated state of the Aβ42-GFP variants, we measured their
distribution between the soluble and insoluble cell fractions using
western blotting (Fig. 6A). Irrespective of whether the proteins can
form PI, the 20 variants were found to be mainly located in the
insoluble fraction, consistently with previous data obtained by our
group and others [39,52]. However, the levels of soluble protein are
higher for polar and charged residues compared to the hydrophobic
ones (Fig. 6B).
The fact that mutants diﬀusely distributed in the cytosol displayed
levels of insoluble protein equivalent or even higher than those forming
PI was surprising (Fig. 6B). This argues that the insoluble fraction might
contain at least two types of aggregates, one corresponding to PI and
the other to proteins that, despite being aggregated, do not coalesce in
visible inclusions, remaining homogenously distributed through the
cytosol; we will call this last type diﬀuse aggregates.
With the aim to localize the protein species generating the oxidative
stress, we analysed whether the measured CellROX ﬂuorescence
correlates with the detected protein levels in either the soluble or the
insoluble fraction. The correlation with the levels of soluble fraction
was higher than with the levels of insoluble fraction (Fig. 6C). From
these results we discarded PI as centres of oxidative stress and
considered two possible interpretations: (i) the soluble species them-
selves correspond to the reactive forms, or (ii) the diﬀuse aggregates are
the reactive forms and the levels of soluble protein are just a reﬂection
of the levels of these disseminated assemblies in the insoluble fraction.
In order to discriminate between these two possibilities, we sought to
design a novel Aβ42 variant with enhanced solubility, in such a way
that the amount of protein in the soluble fraction would be higher than
the amount in the insoluble one, while keeping sequence changes to a
minimum. If the soluble species are the ROS promoting forms, we
expected oxidative stress levels being higher in this mutant than in any
other variant. Diﬀerent aggregation prediction algorithms coincide to
indicate that Aβ42 peptide consists of two main aggregation-prone
stretches, comprising residues 17–21 and 30–41 (Fig. 7A). In the solid-
state NMR, the structure of Aβ amyloid ﬁbrils demonstrates that the
residue Phe19 in the ﬁrst β-strand interacts with Leu34 in the second β-
strand [53]. Based on these data, we introduced in one of the most
soluble and ﬂuorescent variants (Aβ42-F19D) a second mutation by
changing the original Leu at position 34 to Pro (a β-breaking residue), a
combination (19Asp/34Leu) that we have already shown to be highly
soluble in bacteria [54].
In good agreement with the design, 16 h after induction, cells
expressing F19D/L34P variant exhibit a highly ﬂuorescent cytosol
devoid of any PI (Fig. 7B). Fractionation of cell content and immuno-
blotting indicated that, as intended, in 19Asp/34Leu the majority of the
protein was now located in the soluble fraction (Fig. 7C). Quantitative
analysis of the GFP ﬂuorescence of cells expressing the double mutant
using FC indicates that this mutant is by far the most ﬂuorescent variant
in the protein set (Fig. 7E). Despite these properties, the levels of
protein carbonylation (Fig. 7D) and oxidative stress (Fig. 7F) that it
induced were moderate, which discards the possibility of soluble
species being the main elicitors of oxidative damage. To asses if this
eﬀect is caused instead by diﬀuse aggregates, we took proﬁt of the
kinetics of protein aggregation. Therefore, we expressed the double
mutant for 48 h. At this time point, even if the ﬂuorescence remains
diﬀusely distributed in the cytosol (Fig. 7B), the large majority of the
protein is now located in the insoluble fraction (Fig. 7C). Thus, in these
conditions, the double mutant resembles Gln variant after 16 h of
induction of protein expression. We also expressed Gln, Thr and Ile
mutants for 48 h and monitored the distribution of GFP ﬂuorescence in
the cytosol at this time point (Fig. 8A). A proportion of Gln expressing
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cells begin to display PI, the inclusions of Thr become similar to those of
Ile at the 16 h, and in yeast cells expressing Ile variant all the
ﬂuorescence is concentrated in PI at 48 h. Comparison of the relative
levels of oxidative stress for the four mutants at 16 h and 48 h time
points, as determined by using FC (Fig. 8B), allows to visualise that the
highest oxidative stress is attained when the protein is diﬀusely
distributed in the cytosol but located in the insoluble fraction like in
the case of Gln at 16 h or the double mutant at 48 h, whereas the
formation of PI inclusions results in reduced levels of oxidative stress.
After 48 h, cells expressing the double mutant display slightly lower
viability than the other variants (Fig. 8C), whereas at 16 h it is the Gln
variant that induces the highest mortality (Fig. 8C).
To further understand the properties of these diﬀuse aggregates we
addressed whether they might display a compact structure by monitor-
ing their accessibility to proteinase K (PK) (Fig. 8D). Despite its high
activity for cleaving peptide bonds, PK cannot attack the highly packed
backbones in an amyloid β-sheet structure. The insoluble fractions of
cells expressing Ile, Thr, Gln and 19Asp/34Leu variants were treated
with PK up to 10 min. Interestingly, at 16 h the aggregated fraction of
Gln cells was essentially resistant to proteolysis. The same was true for
the insoluble fraction of 19Asp/34Leu after 48 h, which indicates that
diﬀusely distributed aggregates already possess an amyloid-like con-
formation able to elicit the oxidative stress response. The lower levels of
insoluble Ile protein at 48 h suggest that this mutant resembles now Trp
or Phe at the 16 h, becoming a substrate for active degradation.
The above observed inﬂuence of the aggregation kinetics on ROS
promoted levels, predicts that at early times, when aggregation-prone
mutants still haven't been compacted in large and localised inclusions,
these variants would promote more oxidative stress and cytotoxicity
than their more soluble counterparts. To validate this prediction, Gln
and Ile mutants were analysed 8 h after induction of protein expression.
At this time point, Gln ﬂuorescence was homogenously distributed in
the cytosol, whereas in the case of Ile, multiple small ﬂuorescent foci
were already observable in the cells (Fig. 9A). As expected, the levels of
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GFP ﬂuorescence, measured by FC, were higher in Gln expressing cells
(Fig. 9B), but contrary to what was observed at 16 h, after 8 h of
expression it is the more aggregation-prone Ile variant that exhibits the
highest levels of oxidative stress (Fig. 9C) and the lowest viability
(Fig. 9D).
4. Discussion
Many late-onset neurodegenerative diseases are linked to the
presence of aggregation-prone proteins [1–5]. It has been observed
that mutations causing or exacerbating these proteinopathies increase,
in many cases, the protein propensity to form aggregates, thus linking
the formation of protein deposits in the brain and the degeneration of
the nervous system [55]. Also, there are mounting evidences for a
major contribution of oxidative stress in the pathology of these
disorders [56,57], with clear indications of oxidative damage to lipids,
proteins and DNA in patient’s post-mortem brains [19,24,26,27]. The
connection between protein aggregation propensity and oxidative stress
has been demonstrated in models of HD, where the aggregation
tendency of the protein is determined by the length of the poly(Q)
expansion, longer poly(Q) stretches being more aggregation-prone and
inducing higher ROS production than shorter segments in wild type
sequences [58]. However, a systematic quantitative investigation of the
relationship between protein aggregation propensities and intracellular
oxidative stress is still missing. In the present work, we addressed this
issue, taking advantage of a set of 20 Aβ variants diﬀering in a single
residue, but displaying a continuous range of aggregation propensities
when expressed in the yeast cytosol. The obtained data have allowed us
to dissect the contribution of the diﬀerent species populating the
aggregation reaction to intracellular ROS production.
The diﬀerent aggregation properties of the 20 Aβ42-GFP variants in
the present study translate into a binary ability to form PI, half of the
proteins forming visible aggregates and the rest remaining diﬀusely
distributed in the cytosol. This illustrates the exquisite control that the
sequence exerts on in vivo aggregation propensities, since these fusions
diﬀer in a single amino acid out of more than 300 residues. Indeed,
above the PI formation threshold, there is a linear correlation between
the aggregation propensity of a sequence and its recruitment into PI
(Fig. 1C).
As for poly(Q) extensions [58], we expected that the oxidative insult
would increase as the aggregation propensities of the expressed variants
augmented. However, we found exactly the contrary, an almost perfect
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Fig. 7. Characterisation of Aβ42-F19D/L34P variant. (A) Structure of Aβ42 peptide (PDB: 2OTK) showing the side chains of double mutant, F19 in red and L34 in blue. (B) Representative
ﬂuorescence microscopy images of yeast cells expressing Aβ42-F19D/L34P-GFP variant for 16 and 48 h showing GFP ﬂuorescence. Scale bar represents 10 µm. (C) Western blotting of the
soluble (S) and insoluble (I) cell fractions of the mentioned variant after 16 and 48 h of expression. Detected bands correspond to MW =35 kDa. (D) Immunodetection of protein
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probe (APC-A channel) (levels of oxidative stress) of P3 population determined by FC. Error bars represent CV of the FC gated cells.
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Fig. 8. Comparison between GFP ﬂuorescence, oxidative stress levels, cell viability and proteinase K (PK) resistance for Aβ42-GFP mutants after 16 and 48 h of expression. (A)
Representative ﬂuorescence microscopy images showing GFP signal of yeast cells expressing selected Aβ42-GFP variants (Gln, Thr, Ile and F19D/L34P) for 48 h. Scale bar represents
10 µm. (B) CellROX median ﬂuorescence bar graph of yeast cultures expressing selected Aβ42-GFP variants induced for 16 and 48 h determined by FC analysis. Error bars represent CV
from 10,000 events. (C) Percentage of IP positive cells in cultures expressing selected Aβ42-GFP variants induced for indicated times. Error bars represent± SE (n=3). (D) Time-lapse PK
resistance of insoluble fractions of selected Aβ42-GFP variants, induced for 16 and 48 h, detected by western blotting. Detected bands correspond to MW =35 kDa. Cells expressing GFP
alone were used as control.
A. Carija et al. Redox Biology 12 (2017) 699–711
708
negative correlation (r =0.91 and slope =1) between the protein
aggregation potential and the oxidative stress it elicits. Accordingly, the
proteins in the set can be classiﬁed in two classes: I) variants with low
aggregation propensity and high oxidative stress and II) mutants with
high aggregation tendency and low oxidative potential. Cells expressing
class I mutants produced signiﬁcantly higher levels of hydrogen
peroxide and contained signiﬁcant higher catalase activity than class
II variants, indicating that they suﬀer from a higher oxidative stress that
activates the antioxidant defences. Expression of class I mutants also
resulted in a higher level of insoluble carbonylated proteins and a lower
viability. As a general trend, in the ﬁrst class we ﬁnd polar and charged
residues with low β-sheet propensity in position 19 of Aβ42, whereas in
the second one we ﬁnd hydrophobic residues with higher β-sheet
tendency. Again, this observation was counterintuitive, since in aggre-
gation-prone proteins more hydrophobic variants are usually associated
with disease early onset [59]. Importantly, variants in the ﬁrst class do
not form observable PI, in contrast to those in the second class, which
discards PI as the elicitors of oxidative damage (Fig. 1). Confocal
microscopy clearly shows that PI do not produce signiﬁcant levels of
ROS (Fig. 3) and, indeed, it appears that sequestering the most
aggregation-prone variants in PI is as eﬀective to abrogate oxidative
stress as their active degradation by the proteostasis machinery (Fig. 5).
The binary ability of Aβ42-GFP variants to form/not form PI,
together with the lack of oxidant activity of these macromolecular
assemblies, indicated that the diﬀusely distributed protein should
include the reactive species. Contrary to what it was expected, it turned
out that even in the less aggregation-prone mutants, in which PI were
never observed, a large majority of the protein was located in the
insoluble cell fraction. This reveals that, at least for our model, most of
the protein homogeneously distributed through the cytosol is insoluble
and correspond to what we call diﬀuse aggregates. Moreover, from this
observation it becomes evident that inclusions and aggregates are not
interchangeable terms. Engineering a highly soluble 19Asp/34Leu
Aβ42-GFP variant we could discard the soluble, likely monomeric
protein, as a signiﬁcant source of ROS and assign this property to the
diﬀuse aggregates. It is likely that, according to their aggregated and
protease resistant nature, these species correspond to oligomeric and/or
protoﬁbrillar assemblies [20]. Our data are consistent with in vitro
assays on Aβ40 showing that maximum production of free radicals
occurs early in the aggregation reaction, where these small assemblies
are maximally populated [60]. This will explain why the Ile variant is
more toxic than Gln early after induction of protein expression (8 h)
(Fig. 9), but this relationship is inverted at longer times (Figs. 2 and 8).
Comparative analysis of the distribution, solubility and oxidative stress
for diﬀerent Aβ42-GFP variants at 16 and 48 h, suggest that when the
protein aggregates are immobilized in intracellular PI, they are less
dangerous, in agreement with the observation that in vitro formed Aβ40
mature ﬁbrils exhibit a negligible oxidative potential [60]. Therefore,
oxidative stress can be predicted just by monitoring the levels of diﬀuse,
but aggregated species at a certain time point.
In folded proteins, hydrophobic residues are buried inside the core
and their exposure is taken by the cell as an indicative of misfolding and
is suﬃcient to target proteins to inclusion bodies [61]. We have
observed that, due to its composition and short length, the intracellular
expression of Aβ42 mimics the conditions of a misfolded conformer.
The central hydrophobic cluster of Aβ42 includes residues 17–21
(LVFFA), thus the placement of a polar or charged residue in the
central 19 position might disrupt this stretch and abrogate the
misfolding recreation. This will explain why all the variants displaying
hydrophobic mutations were recruited into PI whereas the most of the
charged and polar ones were not [62]. This eﬀect has been observed in
vivo for the Aβ Arctic mutation (E22G), in which the removal of a
ﬂanking charge results in an enhanced formation of large PI, a
reduction of the oligomer levels and decrease of the functional deﬁcits
in a transgenic mice model [63].
Our data provide evidence for a causal link between the accumula-
tion of diﬀuse aggregates and cellular oxidative stress and suggest that
PI formation acts as a second line protective strategy against the
intracellular oxidative stress caused by these species. These ﬁndings
are consistent with previous data with poly(Q)-expanded huntingtin
Fig. 9. Characterisation of GFP ﬂuorescence, oxidative stress levels and cell viability for S. cerevisiae cultures expressing Gln and Ile Aβ42-GFP mutants for 8 h. (A) Representative
ﬂuorescence microscopy images of yeast cells expressing selected variants for 8 h. Scale bar represents 10 µm. (B) Median ﬂuorescence values of expressed GFP from 10,000 cells
determined by FC analysis (FITC-A) for selected Aβ42-GFP variants. (C) CellROX median ﬂuorescence intensity (APC-A) (as indicator of oxidative stress levels) determined by FC in
selected Aβ42-GFP variants. Error bars represent CV of the FC gated cells (P3 population). (D) The percentage of IP positive cells (as indicator of cell mortality) was obtained by FC
analysis (PerCP-Cy5-A) for selected variants. Error bars represent± SE (n=3). Cells expressing GFP alone were used as control.
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[64], ataxin-1 [65], androgen receptor [66] and α-synuclein [67],
demonstrating a dissociation between PI formation and cell death. Our
results have important implications for the therapeutics of the neuro-
degenerative disorders linked to protein aggregation. Approaches
intended to prevent the formation of PI in the brain can convert a
locally recruited inert protein into a toxic aggregated molecule
disseminated around the cell, prolonging oxidative stress and the
associated neurotoxicity. This is consistent with the observation that
pharmacological or genetic disruption of the physiologic processes
required for PI formation results in increased proteotoxicity [21,67]. On
the other way around, reducing the lifetime of protein aggregates and/
or promoting their sequestration into PI appear as worth to explore
therapeutic strategies for the treatment of protein aggregation asso-
ciated diseases [68].
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